The Synapse Life Science Competition is designed to help move innovative life science products and services out of the lab and into the market. The top-ranked teams will deliver a business pitch, competing for up to $60,000 in cash and in-kind prizes.

The 2018 Nobel Prize in Physics was awarded jointly to Canadian Donna Strickland and co-laureate Gérard Mourou, whose research paved the way towards the shortest and most intense laser pulses created by humankind. Dr. Strickland is an associate professor at the University of Waterloo, and is one of three women to receive the Nobel Prize in Physics.

The Centre for Aging + Brain Health Innovation (CABHI), led by Baycrest, has announced support for the development and validation testing of 31 new innovations in aging and brain healthcare, resulting in a total of $1.4 M in support through CABHI’s Spark program.

Vasomune Therapeutics, a leading biotechnology company developing therapeutics targeting vascular dysfunction and inflammation, announced that Douglas A. Hamilton has been appointed President and Chief Executive Officer of the company.

The University of Waterloo announced a 4-year, $400,000 partnership with Manulife Financial to support artificial intelligence research in disability claim prediction as well as fraud detection and natural language comprehension in customer service.

Syng Pharmaceuticals is working with the Impact Centre to develop a new non-invasive diagnostic test for endometriosis, an immunologic condition affecting one in ten women.

Cyclica announced a multi-phase collaboration with Eurofarma to advance drug discovery programs by driving insights into small molecule polypharmacology.

Nanology Labs (OBIO Pre-CAAP 2018) was one of six companies to receive $50,000 from the Ontario Brain Institute's ONtrepreneurs program - Canada’s largest single award focused on neurotechnology.

Therapure Biomanufacturing announced approval for the manufacturing of partner Insmed’s ARIKAYCE® at its Mississauga facility by the U.S. FDA. ARIKAYCE is the first and only treatment approved by the FDA specifically for patients with Mycobacterium avium complex lung disease, a chronic and debilitating condition that can significantly increase patient morbidity and mortality.

The 2018 Nobel Prize in Physiology or Medicine was awarded jointly to James P. Allison and Tasuku Honjo “for their discovery of cancer therapy by inhibition of negative immune regulation.”

HealthTO meetups bring together the Toronto healthcare community to discuss topics related to the future of innovation in health and wellness. On October 10, hear from Jay Couse, CEO and Co-Founder of Spxtrm Health (OBIO Pre-CAAP 2017 Company).

H2i's Pitch Perfect Competition celebrates and supports student innovations on Health Matters. Six early stage innovations will be selected for the pitch competition where three Student Innovation Fellowships of $5,000 will be awarded on Wednesday Nov 7th, 2018.

Flosonics Medical was accepted into the Lazaridis Scale-Up program, which helps 10 growth-stage companies grow networks and prepare for their next round of funding.

This report examines the shape of the health technology industry in Canada with a focus on three specific questions: Does Canada actually have a problem with health tech commercialization? If so, how extensive is that problem? And what is causing it?

BIOTECanada and Deloitte collaborated on the Biotechnology Industry Data Survey in an effort to identify key data points outlining the characteristics of the sector across geographies and subsectors, and to describe its economic footprint on the country.

Originating in Canada in 2003, Biotech Week is now recognized around the world as Global Biotech Week. Events scheduled throughout the United States, Europe, Australia, and Canada highlight the innovation and creativity of life science researchers.

Sunnybrook is conducting three Medventions Lectures on Thursday evenings in October. The first lecture, An Introduction to Patents for the Medical Device Researcher , will be held on October 4th, 5PM - 8PM at the Sunnybrook Health Sciences Centre.

VBI Vaccines announced the formation of three Scientific and Clinical Advisory Boards consisting of leading experts in infectious disease and immuno-oncology research and vaccine development.

MaRS and the University of Toronto announced they will be leasing 24,000 square feet of office space in the Waterfront Innovation Centre, a development on the inner harbour near Sugar Beach, when it opens in 2021.

The third annual Medicine by Design Symposium will bring together principal investigators and trainees from across the University of Toronto and affiliated hospitals, along with members of Medicine by Design's Scientific Advisory Board, to share research and ignite new collaborations.